Balton_logo (1)

The BALTON Company was founded in 1980 as an affiliated company of the French BALT Extrusion S.A., manufacturer of high precision intracerebral catheters and stents. During those thirty-four years, the BALTON Company, making use of the French technology, has created a large range of medical products intended for use in anesthesiology, surgery, urology, gynecology, cardiology, and radiology. A few of each have been specified herein below:

Anaesthesiology: – Epidural Kits in different sets and sizes, Catheterization Sets and other accessories
Surgery: – Embolectomy Catheters
Urology: – Nephrostomy and Cystostomy Kits, Dialysis Catheters, Sets for Stent Introduction, and others
Two of the most important areas include cardiology and invasive radiology. These are such high-class catheters as:

  • Diagnostic Catheters
  • Catheters for Coronary and Peripheral Angioplasty: RIVER, FRYDERYK, PBA
  • Valvuloplasty Catheters: VALVER
  • Steel, cobalt-chromium and nitinol stents
  • DES stents: LUC-CHOPIN, CARLO S, ALEX, PAXEL and PROLIM, with LUC-CHOPIN 2, manufactured in 2005 as the first stent in the world coated with biodegradable polymer
  • Bifurcation stents: BIOSS EXPERT and BIOSS LIM
  • Kidney stents: NEFRO
  • Carotid stents: MER and Neuroprotection System ROBIN
  • Peripheral stents: NEPTUN and JAGUAR
  • PTCA guidewires
  • Diagnostic guidewires
  • Intra-Aortic Balloon Catheter Set (IABC)
  • Gastroenterology – TROYCA balloons
  • Varicose Vein Treatment Catheter Set – Flebogrif

The BALTON Company employs state-of-the-art technologies and raw materials that are applied in the world in the manufacturing of this type of products. We collaborate with numerous university and medical centers in Poland and worldwide, with those, among others, located in the U.S.A., France, Great Britain, Japan, Brazil, and Russia.


MiMedx delivers innovative bioactive healing products for tissue regeneration

MiMedx is the global premier processor, marketer, and distributor of human amniotic tissue. MiMedx has distributed over 800,000 amniotic tissue grafts worldwide and achieved profound clinical outcomes in multiple therapeutic areas including ophthalmology, spine, chronic wounds, dental, orthopedic surgery, sports medicine, and urology.  With this groundbreaking human tissue offering that promotes bioactive healing, MiMedx believes its unmatched knowledge and superior processing of amniotic tissue strategically positions the Company to become the leader in regenerative medicine.


In the 1980s, hospital coffee came courtesy of a machine rather than a barista, people expected hospital furniture to be grey and uninspiring, and nurses looking for supplies often had to struggle with heavy drawers and high cupboards.

Then along came Medstor. Launched in 1990, Medstor introduced a materials management system that would banish greyness and inefficiency forever. Beautiful colours and sleek styling housed a solution to even the most complex medical storage issues, designed to ensure supplies were easy to access, easy to monitor, and there where and when you need them most.

Medstor product designers plan and re-plan, design and re-design, test and re-test, constructing prototypes and printing 3D models until customers have the perfect solution. This constant process of reworking and creative problem-solving means that by the time a new Medstor product comes to market, it is, quite simply, right